SCM
ACHV icon

Sterling Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Sterling Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-255
Closed -$681 – 3265
2025
Q1 		$681 Sell
255
-227
-47% -$706 ﹤0.01% 2912
2024
Q4 		$1.7K Buy
482
+418
+653% +$1.89K ﹤0.01% 2822
2024
Q3 		$303 Buy
+64
New +$292 ﹤0.01% 3029

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sterling Capital Management's ACHV Position: Q2 2025 in Review

Sterling Capital Management sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 255 shares — an estimated $681 sold.

Sterling Capital Management first reported a position in ACHV in Q3 2024 and held it in 3 quarters. The position peaked at $1.7K in Q4 2024. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • Sterling Capital Management reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 255 Achieve Life Sciences shares in Q2 2025, an estimated $681.
  • Sterling Capital Management first reported a position in Achieve Life Sciences in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's Achieve Life Sciences position peaked at $1.7K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.